HB1011

unknown (auto-discovered: gene-epigenetic-therapy, peptides-regenerative)

Not graded

Classification

Biologic

Regulatory Status

investigational; registered trials: NCT07861035 (PHASE1)

Unofficial source

Sources

Review

pending review

Overview

Unknown — HB1011 was found by open discovery on 2026-10-26 and has not been researched yet.

Known

n/a

Unknown

Mechanism, dosing, safety, interactions and efficacy are unknown until research runs on this auto-discovered draft.

Study details: trial conditions, not guidance

These are the conditions researchers used in a controlled trial with medical supervision. They aren't instructions.

Doses as found in each source, with its grade. What was found, not a direction.

Studies, trials and professional sources

n/a

Reddit, Facebook, Instagram, forums and blogs

n/a

Not gradedHB1011 is being studied in a registered trial: A Phase I Study of Allogeneic Myocardium-Derived Mesenchymal Stem Cells (HB1011) in Patients With Ischemic Cardiomyopathy (NCT07861035; PHASE1; RECRUITING; sponsor HieraBio Inc.; intervention "HB1011 (Allogeneic Myocardium-derived Mesenchymal Stem Cells)" (BIOLOGICAL)).

Educational reference only — not medical advice.

What people report (anecdote)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

Loading…